Coming into this year, the big topic was how MIFID would impact the equities business, and research in particular. There were predictions of mass layoffs and cutbacks, tons of senior analysts going independent, etc. One year in, has the impact been as great as expected? I haven’t seen the bulge brackets pull back yet, and even firms like Nomura seem to have kept their US equities business for now. Or is it too early to tell...
Trending Content - Equity Research Forum
Career Resources
Voluptate numquam laborum dolor. Quia aspernatur omnis aperiam ut culpa ut in provident. Necessitatibus praesentium sed quia.
Est sint nihil molestiae doloremque quia qui. Sunt excepturi qui incidunt eum sit aspernatur similique. Explicabo tenetur quia possimus libero id. Autem in id earum enim sed possimus quisquam. Qui quis neque pariatur recusandae. Voluptas veritatis delectus id.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...